Shares of Kineta to commence trading on Nasdaq under new ticker symbol “KA” on December 19, 2022 Seattle, WA — (December 19, 2022) Kineta, Inc. (“Kineta” or the “Company”), a clinical-stage biotechnology company focused on developing next-generation immunotherapies to address [...]
BUSINESS WIRE Recon Capital Advisors, LLC (“RCA”), the investment adviser to the four exchange-traded funds that make up the Recon Capital Series Trust, has entered into an agreement to be acquired by Horizons ETFs Management (USA) LLC (“Horizons USA”), a [...]
PR Newswire NEW YORK, Nov. 1, 2016 NEW YORK, Nov. 1, 2016 /PRNewswire/ -- Crunch, the health club chain best known for making serious fitness fun through unique programming and cutting-edge training, announces the opening of its newest franchise location [...]
Kineta, a Seattle-based biotech startup, has raised an investment round worth almost $1.6 million from existing investors in the company. The investment will be used to fund continued development of the drugs that the company is working on. “This new raise [...]
